TLDR Krt16-deficient mice help understand skin disorders like PC and FNEPPK.
Researchers Lessard and Coulombe developed a Krt16-deficient mouse model to study palmoplantar keratoderma, a key feature of pachyonychia congenita (PC) and focal non-epidermolytic palmoplantar keratoderma (FNEPPK). These mice exhibited reduced birth weight, high early postnatal mortality due to hyperplastic tongue lesions, and developed painful calluses on their paws, mirroring human symptoms. The study suggested that both mutant and absent KRT16 proteins lead to similar palmoplantar lesions, highlighting the importance of KRT16 in skin structure and function. However, the Krt16-null mice did not show other PC characteristics like nail dystrophy, indicating different underlying mechanisms for various symptoms.
438 citations,
October 2010 in “Oncogene” Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.
68 citations,
April 2012 in “Journal of Investigative Dermatology” The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.
1 citations,
July 2021 in “IntechOpen eBooks” Environmental factors can cause mutations in skin proteins, leading to skin disorders.
5 citations,
July 2022 in “Orphanet journal of rare diseases” RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.
3 citations,
June 2022 in “European journal of human genetics” A new type of pachyonychia congenita linked to a specific keratin gene mutation was found in two Pakistani families.
3 citations,
March 2023 in “International journal of molecular sciences” Keratin protein production in cells is controlled by a complex system that changes with cell type, health, and conditions like injury or cancer.